Navigation Links
WorldHeart Appoints Morgan Brown as New Vice President of Finance and Chief Financial Officer
Date:8/10/2009

SALT LAKE CITY, Aug. 10 /PRNewswire-FirstCall/ -- ("WorldHeart", Nasdaq: WHRT) World Heart Corporation, a pioneer in cardiac assist technologies, announced today that it has appointed Morgan Brown as Executive Vice President and Chief Financial Officer. Mr. Brown brings over 16 years of experience to WorldHeart.

Mr. Brown joins WorldHeart from Lifetree Clinical Research where he was Chief Financial Officer and Senior Vice President since 2008. While at Lifetree Clinical Research, Mr. Brown oversaw the accounting, finance, human resource, facility and information technology departments.

Previously, Mr. Brown was with NPS Pharmaceuticals Inc., a Russell 2000 public company, from 2000 to 2008, where he served as Vice President Finance and Treasurer. During his tenure at NPS Mr. Brown was involved in numerous financings as well as merger and acquisition activities.

Before NPS, Mr. Brown, 40, worked for KPMG LLP in Salt Lake City. Mr. Brown managed multiple audit engagements, servicing private and publicly owned clients. Mr. Brown is a licensed certified public accountant in Utah and earned a master's degree in business administration from the University of Utah and a bachelor's degree in accounting from Utah State University.

Alex Martin, WorldHeart's President and CEO commented, "I join WorldHeart's Board of Directors and employees in welcoming Morgan to WorldHeart. Morgan brings a wealth of experience in finance and accounting that will be invaluable as WorldHeart transitions its corporate headquarters to Salt Lake City, advances its clinical development programs and grows its overall business."

In addition to his other duties, Mr. Brown will manage the move of the World Heart Headquarters from Oakland, California to Salt Lake City, Utah.

About World Heart Corporation

WorldHeart is a developer of mechanical circulatory support systems headquartered in Salt Lake City, Utah with additional facilities in Oakland, California, USA and Herkenbosch, The Netherlands. WorldHeart's registered office is in Ottawa, Ontario, Canada.

Any forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include all statements relating to the advancement of WorldHeart's clinical development programs and the growth of its overall business, as well as other statements that can be identified by the use of forward-looking language, such as "believes," "feels," "expects," "may," "will," "should," "seeks," "plans," "anticipates," or "intends" or the negative of those terms, or by discussions of strategy or intentions. Investors are cautioned that all forward-looking statements involve risk and uncertainties, including without limitation: WorldHeart's need for additional capital in the future; risks in product development and market acceptance of and demand for WorldHeart's products; and other risks detailed in WorldHeart's filings with the U.S. Securities and Exchange Commission, including without limitation its Annual Report on Form 10-K for the year ended December 31, 2008 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2009 and June 30, 2009.

www.worldheart.com


'/>"/>
SOURCE World Heart Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. WorldHeart Notified of TSX Delisting Review
3. WorldHeart Announces Possible Delisting Action by NASDAQ
4. WorldHeart Announces Voluntary Delisting from the Toronto Stock Exchange
5. WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market
6. WorldHeart Receives Favorable Decision to Continue NASDAQ Listing
7. WorldHeart Announces Effectiveness of Reverse Stock Split
8. WorldHeart Receives Notice From the NASDAQ Stock Market Regarding Non-Compliance With Marketplace Rule 4310(c)(7)
9. WorldHeart Regains Compliance With the Minimum Bid Price Rule
10. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
11. WorldHeart Appoints New President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... New York, NY (PRWEB) , ... April 24, ... ... students in 72 countries clearly shows that over the last decade, student well-being ... have ticked all the boxes of formal education, join the Islamic State to ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to using ... Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 years, ... USA, and former member of the American Association of Christian Counselors. Rachel studied ...
(Date:4/24/2017)... ... 2017 , ... Miami Periodontist and Dental Implant ... Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in Miami Beach ... Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This annual symposium ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology: